High Prevalence of Cardiac Diseases Drives Demand for Cardiac Defibrillators, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Cardiac Defibrillators markets. Global market for Cardiac Defibrillators is projected to reach US$11.2 billion by 2020, driven by factors such as aging population, growing incidence and prevalence of cardiac diseases, and increasing patient awareness over the importance of timely intervention.

Cardiac Defibrillators: A Global Strategic Business Report

Follow us on LinkedIn - Cardiovascular diseases are ranked among the leading causes of mortality across the world. Sudden cardiac arrest represents the single largest cause of death. Defibrillation can prove to be a life-saving technique if employed within few minutes of a cardiac arrest. An aging global population and rising incidence of various cardiovascular diseases are the major driving forces in the global cardiac defibrillators market. Rapid expansion in the number of care facilities, medical institutions, ambulatory trauma care services, hospitals, and emergency care centers, is contributing to increased demand for cardiac defibrillators. Growth in the cardiac defibrillators market is dependent on the pace of technological advancements, and the level of competition. The market is significantly influenced by the advent of newer, advanced technologies, which in turn is driven by the growing demand for quality care. Future growth in the market will be driven by favorable government regulations, focus on reducing the cost of treating cardiac diseases, and technological developments.

Advancements in the area of defibrillators have enabled incorporation of multiple functions such as 12-lead acquisition as well as transmission of ECG data; monitoring and diagnostic capabilities; and ability to provide resuscitation therapies. Novel defibrillators available today incorporate advanced monitoring capabilities such as SPO2, non-invasive blood pressure, and capnography. Other significant advancements are also evident at the product design level. Designed essentially for single chambers, Implantable Cardioverter Defibrillators (ICDs) were initially intended to deliver electric shocks for terminating lethal ventricular rhythm. Devices available today come with a left ventricular lead that enables delivery of CRT (cardiac resynchronization therapy).

Apart from generators and leads, advancements have also taken place over the years at the software front. Developments have combined pacing capabilities and sophisticated programming algorithms for enabling ventricular tachycardia treatment using antitachycardia pacing. Developments are also swift at the automated external defibrillators front. Use of biphasic defibrillators is growing largely due to increasing evidence of their superior success rates in the restoration of normal heart rhythms.

Backed by significant support from governments as well as private parties, global demand for automated external defibrillators (AEDs) is expected to grow at a significant rate. Funding for these devices is increasingly becoming easier with several initiatives being implemented worldwide, especially in developed markets, as a part of the drive to expand public accessibility to AEDs. Factors that will galvanize large-scale adoption of AEDs include small compact size, ease-of-use and affordability. Efficacy levels of the devices are also on the rise, making them more reliable.

As stated by the new market research report on Cardiac Defibrillators, the United States represents the largest market worldwide. Technological advancements, legislation mandates, increase in out-patient services, implementation of risk mitigation mechanisms and an aging population are factors driving growth in the country. Asia-Pacific is forecast to emerge as the fastest growing market with a CAGR of 7.8% over the analysis period.

Major players covered in the report include Biotronik GmbH & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, GE Healthcare Ltd., Medtronic, Inc., Physio-Control Inc., Philips Healthcare, St. Jude Medical Inc., and Zoll Medical Corporation, among others.

The research report titled "Cardiac Defibrillators: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific, Middle East & Africa, and Latin America. The report also analyzes the global market for Cardiac Defibrillators by product segments such as Implantable/Internal Cardiac Defibrillators and External Cardiac Defibrillators.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Cardiac_Defibrillators_Market_Report.asp.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Raghu Gopal
Global Industry Analysts Inc
+1 408-528-9966
Email >
Visit website